In recent years, the need for validated health claims in the form of substantiated science has become somewhat unnegotiable, leading to a considerable increase in the number of businesses investing in clinical trials. More nutraceutical, food and beverage manufacturers involved in the development and commercialisation of their respective products are joining the industry-wide trend through collaboration with research partners that can support clinical investigation and file preparation.
January 31, 2020
The proliferation of clinical data is making it challenging for companies to compete if they lack evidence pertaining to the effects of their products in humans
Randomised, double-blind, placebo-controlled trials have emerged as the gold standard of clinical evidence for drugs, nutraceuticals and functional foods, with boundaries blurring as these sectors look to meet the needs of the same consumers, but with different purchasing approaches
Companies struggling to find investment for clinical trials can gain practical insights through case studies with research teams or smaller-scale pilot trials
CROs and universities are commonly selected as research partners, but there are complex layers that businesses need to consider in their selection process.
.jpg?width=700&auto=webp&quality=80&disable=upscale)
